TripleHormone-Receptor Agonist Retatrutide for Obesity (Jastreboff et al., PubMed)
Sources Eli Lilly press release
Hope the seller will continue to restock more in the future
[14] Although it's not on the label, this ingredient is sold as as Solnul in the dietary supplement market
Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr
Retatrutide is an investigational triple incretin receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, producing appetite suppression, enhanced insulin secretion, and increased energy expenditure, though long-term safety and cardiovascular outcome data are not yet available